EUVIMEDEUVIMED entdecken
Crossref

Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts

Sei Morinaga, Qinghong Han, Yutaro Kubota, Kohei Mizuta, Byung Mo Kang, Motokazu Sato, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi und 3 weitere

Anticancer Research · 2024-03 · 44 (3) · 921-928

DOI: 10.21873/anticanres.16886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.02.2024. Verfasst von Sei Morinaga und 14 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Fibrosarcoma, Polyether Polyketides, Furans. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon-Sulfur LyasesFibrosarcomaPolyether PolyketidesFuransKetonesHumansCell Line, TumorFibroblastsRecombinant Proteins

Stichwörter der Autor:innen

Hoffman effectMethioninasecombinationeribulinfibrosarcomain vitromethionine addictionmethionine restrictionnormal fibroblastssynergy

Substanzen

L-methionine gamma-lyaseeribulinCarbon-Sulfur LyasesRecombinant ProteinsPolyether PolyketidesFuransKetones

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Morinaga, S., Han, Q., Kubota, Y., Mizuta, K., Kang, B. M., Sato, M., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Tsuchiya, H., & Hoffman, R. M. (2024). Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts. Anticancer Research, 44(3), 921-928. https://doi.org/10.21873/anticanres.16886

Vancouver

Morinaga S, Han Q, Kubota Y, Mizuta K, Kang BM, Sato M, et al. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts. Anticancer Research. 2024;44(3):921-928. doi:10.21873/anticanres.16886

BibTeX
@article{Morinaga2024,
  author = {Morinaga, Sei and Han, Qinghong and Kubota, Yutaro and Mizuta, Kohei and Kang, Byung Mo and Sato, Motokazu and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Tsuchiya, Hiroyuki and Hoffman, Robert M},
  title = {Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts},
  journal = {Anticancer Research},
  year = {2024},
  volume = {44},
  number = {3},
  pages = {921--928},
  doi = {10.21873/anticanres.16886}
}
Kostenlos starten →